Belfast · Northern Ireland
Retrospective archiveHistorical reports were compiled from linked contemporaneous sources. Dates refer to the events covered.How the archive works

Moderna begins a study and a phase 2 trial of a hybrid vaccine aimed at combating the Omicron variant with their current COVID-19 vaccine

Moderna begins a study and a phase 2 trial of a hybrid vaccine aimed at combating the Omicron variant with their current COVID-19 vaccine.

Herald Premium Archive

This report is for subscribers

Sign in or choose a plan to read this report and the complete Premium retrospective archive.

HealthModerna begins a study and a phase 2 trial of a hybrid vaccine aimed at combating the Omicron variant with their current COVID-19 vaccine

Moderna begins a study and a phase 2 trial of a hybrid vaccine aimed at combating the Omicron variant with their current COVID-19 vaccine.

View Premium plansBrowse free archive reports